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Tissue tropism and pathogenesis of influenza A virus
subtype H5N1 disease in humans is not well defined. In
mammalian experimental models, H5N1 influenza is a dis-
seminated disease. However, limited previous data from
human autopsies have not shown evidence of virus dis-
semination beyond the lung. We investigated a patient with
fatal H5N1 influenza. Viral RNA was detected by reverse
transcription–polymerase chain reaction in lung, intestine,
and spleen tissues, but positive-stranded viral RNA indicat-
ing virus replication was confined to the lung and intestine.
Viral antigen was detected in pneumocytes by immunohis-
tochemical tests. Tumor necrosis factor-α mRNAwas seen
in lung tissue. In contrast to disseminated infection docu-
mented in other mammals and birds, H5N1 viral replication
in humans may be restricted to the lung and intestine, and
the major site of H5N1 viral replication in the lung is the
pneumocyte.
H
ighly pathogenic avian influenza virus H5N1 is the
first avian influenza virus that was documented to
cause respiratory disease and death in humans (1–3). In
2004, it caused widespread disease in poultry in Asia (4)
and led to human disease in Thailand and Vietnam, with
reported fatality rates of 66% and 80%, respectively (5,6).
With the emergence of a second wave of disease outbreaks
in poultry in Thailand, Vietnam, and Indonesia, this dis-
ease poses a global threat to human health (4). Additional
human cases have been reported since August 2004. The
high pathogenicity of this virus in avian species is associ-
ated with readily cleavable hemagglutinin (HA), but other
amino acid residues in HA and neuraminidase have been
recently reported to be involved in avian pathogenicity (7).
In mice, some H5N1 virus strains cause a disseminated
infection and death, and this phenotype was associated
with specific amino acid substitutions in PB2 and the
multibasic cleavage site in HA (8). Natural infection of
felines with H5N1 viruses also resulted in disseminated
infection (9). However, the pathogenesis of H5N1 disease
in humans is more obscure. Despite severe and generalized
clinical manifestations, the result of multiple organ dys-
function, previous limited autopsy data failed to show evi-
dence of viral replication beyond the respiratory tract
(10,11). The tissue tropism of the virus in humans has also
not been clearly established by immunohistochemical
analyses (10,11). The absence of detectable viral
antigen–positive cells in previous reports may relate to the
fact that the patients died during the late phase of the dis-
ease after intensive treatment with antiviral drugs. In this
report, we investigated a case of fatal H5N1 disease in a
child for tissue tropism caused by the virus in the lungs and
other organs. 
Methods
Patient and Virologic Diagnosis
Detailed clinical description of the patient is reported
elsewhere (12). The patient was a 6-year-old boy who had
a progressive viral pneumonia that led to acute respiratory
distress syndrome and death 17 days after onset of illness.
He was initially treated with multiple broad-spectrum
antimicrobial agents. Virologic diagnosis of H5N1 infec-
tion was made on day 7 of illness. After oseltamivir
became available in Thailand, he was treated on day 15 of
his illness with this agent until he died. He was also treat-
ed with methylprednisolone on day 15 until death and with
granulocyte colony-stimulating factor for leukopenia from
day 5 to day 10 of illness. 
Virologic diagnosis was made by antigen detection,
viral culture, and reverse transcription–polymerase chain
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Republic of China reaction (RT-PCR) on a nasopharyngeal wash specimen as
described (12) and was confirmed by seroconversion of
neutralizing antibody against H5N1 virus. The virus was
identified as avian influenza virus (H5N1) by whole
genome sequencing. The virus was an avian virus with no
evidence of genetic reassortment with human influenza
viruses. Phylogenetic analysis showed that the viral
genomic sequence formed a distinct cluster with other
H5N1 viruses isolated from humans and poultry in
Thailand and Vietnam, but it was still related to the previ-
ously described H5N1 viruses circulating in southern
China. As with other viruses isolated from poultry in
Vietnam, Thailand, and Indonesia, this virus was also a
genotype Z virus (4).
Pathologic Examination
Autopsy was carried out by standard techniques, and
precautions were taken to minimize risk of transmission of
infection. The tissue obtained was prepared for routine his-
tologic analysis, and a portion was stored at –70°C for fur-
ther study. For RT-PCR, fresh unfixed specimens were
minced into small pieces in lysis buffer of an RNA extrac-
tion kit (RNA Wizard, Ambion, Austin TX, USA). Total
RNA was then extracted according to the manufacturer’s
protocol. RNAwas also extracted from paraffin-embedded
tissues by sequential extraction with TriZol reagent
(Invitrogen, Carlsbad, CA, USA) and the RNAEasy kit
(Qiagen, Valencia, CA, USA) after digestion with pro-
teinase K. RT-PCR for H5 was then conducted on extract-
ed RNA by using One Step RT-PCR kit (Qiagen) with the
H5 specific primer pairs H5F (5′-ACTCCAATGGGGGC-
GATAAAC-3′) and H5R (5′-CAACGGCCTCAAACT-
GAGTGT-3′) (13). An RT-PCR for glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) mRNAwas done in
parallel to control for the amount and quality of RNA as
described (14). Strand-specific RT-PCR was carried out by
a method similar to RT-PCR for viral RNA detection,
except that only 1 primer was added at the reverse tran-
scription step.
For immunohistochemical analysis, sections were
deparaffinized and rehydrated. Antigenic site retrieval was
accomplished by heating each slide in a microwave oven
at 700 W for 15 min in 0.05 mol/L citric acid buffer, pH
6.0, and cooling for 20 min at room temperature.
Endogenous peroxidase activity was blocked by incubat-
ing the slides in 0.3% H2O2 for 30 min at room tempera-
ture. Sections were incubated with 20% normal goat serum
(Dako, Glostrup, Denmark) for 20 min at room tempera-
ture and then with an anti-influenza A nucleoprotein mon-
oclonal antibody at a 1:100 dilution (B.V. European
Veterinary Laboratory, Woerden, the Netherlands) for 1 h
at room temperature. Slides were rinsed 3 times in 0.05
mol/L Tris-buffer, pH 7.6, 0.1% Tween 20 and incubated
with horseradish peroxidase–conjugated goat anti-mouse
immunoglobulin at a 1:400 dilution (Dako) for 30 min at
room temperature. The slides were washed as above,
developed with diaminobenzidine (Dako), and counter-
stained with hematoxylin. Some slides of lung tissue were
double-stained with a monoclonal antibody (1:50 dilution)
against surfactant (Dako).
Cytokine Expression
Tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ),
and interleukin-6 (IL-6) mRNA were detected in the
extracted RNA by an RT-PCR with previously described
primer pairs (15–17). Plasma levels of TNF-α and IFN-γ
were measured by enzyme-linked immunosorbent assay
(Pierce Endogen, Rockford, IL, USA) and compared with
samples from 3 H3 influenza–infected patients and 5
healthy persons.
Results
The autopsy showed proliferative phase of diffuse alve-
olar damage, interstitial pneumonia, focal hemorrhage, and
bronchiolitis. The pneumocytes showed reactive hyperpla-
sia without virus-associated cytopathic changes (Figure 1).
Superimposed infection by fungus, morphologically con-
sistent with aspergillosis, was seen in some areas of the
lung. The lymph nodes, spleen, and bone marrow showed
slight histiocytic hyperplasia. No evidence of hemophago-
cytic activity was seen. The liver had mild fatty changes,
activated Kupffer cells, and slight lymphoid infiltration in
the portal areas. The brain was edematous, and small foci
of necrosis were found. Intestines, kidneys, heart, and
other organs showed no remarkable changes.
H5-specific RNA was detected in the lung, spleen, and
small and large intestines by RT-PCR (Figure 2A). Control
reactions without the reverse transcription step were nega-
tive, confirming that the PCR amplicon was not contami-
nated. The successful extractions of RNA from all organs
were confirmed by the amplification of GAPDH mRNA
(data not shown). We also tested whether the RNA was
genomic RNA from virion or replicating RNA and mRNA
from productively infected cells. To determine this, we
conducted strand-specific RT-PCRs. Positive- and nega-
tive-stranded viral RNAwas found in the lung, small intes-
tines, and large intestines, but only negative-stranded RNA
was detected in the spleen (Figure 2B). Because of the
absence of positive-stranded RNA, which would serve as
mRNA and the template for genome replication, we con-
cluded that viral replication was absent or very low in the
spleen and that the viral RNA detected in the spleen was
probably nonreplicating virion RNA. No evidence of viral
RNA was seen in the adrenal glands, brain, bone marrow,
kidneys, liver, or pancreas. Results of the RT-PCR for viral
RNA in plasma were also negative.
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virus antigen-positive cells in lung tissue. The staining was
localized in nuclei of alveoli-lining cells. Positive cells
were found in 4 of 9 blocks of lung tissue. The shape and
location of the antigen-positive cells indicated that they
were type II pneumocytes. To confirm this, we used sur-
factant as a marker of type II pneumocyte (18). We double-
stained slides from adjacent cuts with anti-influenza Aand
anti-surfactant monoclonal antibodies and showed that all
influenza virus antigen–positive cells with nuclear staining
showed intracytoplasmic staining of surfactant (Figure 3).
Slides stained only with antibodies to surfactant showed
intracytoplasmic, not intranuclear, staining. This finding
confirmed that viral antigen–positive cells were type II
pneumocytes. Although viral mRNA was present in the
intestines, viral antigen was not detected in 4 blocks of tis-
sue from the small and large intestines. In accordance with
the absence of viral mRNA in other organs, viral antigen
was not detected in those tissues. We also tested 2 blocks
of tissue from the trachea. We did not detect any positive
staining in columnar epithelium, which is the usual target
for influenza virus infection in humans (19), which sug-
gests that the virus targeted primarily lung tissue and not
airway epithelium. Similarly, we did not find viral antigen
in bronchiolar epithelium in the lung sections. Columnar
epithelium in both the trachea and bronchiole was intact,
thus providing adequate columnar epithelial cells for eval-
uation. The lack of pathologic changes is consistent with
the absence of viral infection in these tissues. 
The high pathogenicity of the H5N1 avian influenza
virus has been proposed to be caused by induction of
proinflammatory cytokines (20). Cytokine dysregulation
could be the major cause of tissue damage in humans,
especially in organs in which productive infection does not
take place and cell damage cannot be accounted for by
cytolytic viral infection. To investigate this aspect of viral
pathogenesis, we tested for the presence of cytokine
mRNAin tissues from various organs. We detected TNF-α
mRNA in lung tissue, but not in other organs (intestines,
stomach, spleen, brain, bone marrow, kidneys, liver, and
pancreas) of this patient, or in lung tissue of patients who
died of other causes (Figure 2C). We did not find any
increase in levels of IFN-α, IFN-γ, and IL-6 mRNA in
organs of this patient when compared with control tissues
from healthy persons. 
In accordance with previous reports showing the
increased levels of serum cytokines, we found high levels
RESEARCH
1038 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 7, July 2005
Figure 1. Microscopic shape of the lung showing proliferative
phase of diffuse alveolar damage and interstitial pneumonia with
reactive hyperplasia of pneumocytes (magnification x100).
Figure 2. A) Detection of H5 influenza viral RNA
in lungs, intestines, and spleen by reverse tran-
scription-polymerase chain reaction (RT-PCR). B)
Strand-specific RT-PCR detected positive-strand-
ed viral RNA only in lungs and intestines but not
in spleen. +/–, total RNA; –, negative-stranded
RNA; +, positive-stranded RNA. RT-PCR prod-
ucts of an infected cell culture pellet and super-
natant are shown as a control for proper
amplification of the specific strands (lower panel).
C) Tumor necrosis factor-α (TNF-α) mRNA was
detected by RT-PCR only in lung tissue of the
patient but not in lung tissue from a healthy con-
trol.of interferon-induced protein 10 in serum samples collect-
ed on day 5 (37,000 pg/mL) and day 10 (4,300 pg/mL) of
illness. These levels are comparable to those reported in
H5N1-infected cases (10). However, we could not detect
any significant levels of TNF-α and IFN-γ in these
samples.
Discussion
Detailed autopsy data on patients with H5N1 disease
are limited, and our data provide an insight into the patho-
genesis of H5N1 virus in humans. We provide evidence
that H5N1 viral replication is not confined to the respirato-
ry tract but may also occur in the gastrointestinal tract.
However, a fecal sample was not available for detection of
virus. Although viral RNA was detected in the spleen, no
evidence of viral replication was seen in this organ. The
patient was treated with an antiviral agent for 2 days before
death, which could have lowered the level of viral replica-
tion in the examined tissues. However, we still found viral
mRNA in lungs and intestines, indicating that the viral
replication was still ongoing. Viral replication in lungs and
intestines was greater than in other sites. Our data agree
with previous reports of human cases and cases in experi-
mentally infected macaques, which also suggest that H5N1
influenza virus replication takes place predominantly in
the lungs (10,11,21). We also show that type II pneumo-
cytes, not columnar tracheal epithelial cells, are the major
site of H5N1 viral replication in humans. Type II pneumo-
cytes are surfactant-producing, alveolar epithelial cells and
progenitor cells of both type I and type II cells. This cell
type has been shown to contain sialic acid in newborn
human lung (22). Whether the availability of the receptor
alone determined the site of H5N1 infection needs further
investigation. 
Infection of the gastrointestinal tract by avian influenza
virus, including H5N1, is common in avian species
(23,24). However, involvement of the gastrointestinal tract
in H1 and H3 influenza infection is rare in humans (25). A
patient with H5N1 influenza virus infection was reported
to have diarrhea as the initial symptom, which raises the
question of whether the gastrointestinal tract may is anoth-
er site of viral replication and shedding, similar to its func-
tion in avian species (26). In another recent report of a
patient with a fatal H5N1 infection and severe diarrhea and
encephalitis in Vietnam, the virus was found in a rectal
swab (27). Our data confirm that H5N1 influenza virus
replication can occur in the gastrointestinal tract even in
the absence of diarrhea. However, we do not know the
extent of viral shedding in stool in this patient. The
absence of pathologic changes in the intestine, despite the
viral replication, is intriguing. 
The absence of viral antigen in the trachea indicated
that the upper airway is probably not an active site of the
viral replication. This finding is in marked contrast to the
circumstances with human influenza, in which the upper
respiratory tract and the tracheal and bronchial epithelium
are primarily targeted (19). The predilection of H5N1
influenza virus for the lower airways may explain why
detecting virus in upper airway specimens for diagnosis of
H5N1 infection in humans is difficult (1). This finding also
implies that specimens from the lower respiratory tract,
such as sputum or bronchoalveolar lavage, would have a
higher sensitivity for viral detection than an upper respira-
tory specimen, such as nasopharyngeal aspirates or throat
swab specimens. Our data showing the absence of viral
antigen in columnar epithelial cells contrast with a recent-
ly published report that H5N1 viral replication took place
selectively in ciliated bronchial epithelial cells in an in
vitro culture model (28). Whether this result was due to
properties of specific viral strains or a difference attributa-
ble to the in vitro model needs further clarification.
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Figure 3. Immunohistochemical analysis showing influenza A anti-
gen-specific staining in nuclei of cells lining the alveoli (A). To iden-
tify the cell type, slides from consecutive sections were stained
with anti-influenza A antibody (B) and double-stained with anti-
influenza A and antisurfactant antibodies (C). The sections were
mapped, and the same area in each section was examined. Viral
antigen-positive cells were stained both intranuclearly with anti-
influenza antibody and intracytoplasmically with antisurfactant
antibody, indicating that the viral antigen-positive cells were type II
pneumocytes. Viral antigen-positive cell are marked by circles
(magnification x400).In contrast to previous reports (10,11), we did not find
prominent hemophagocytosis in any of the organs. The
presence of hemophagocytosis in these reports supports
the cytokine dysregulation model of pathogenesis.
Whether the young age of our patient or prior treatment
with immunosuppressive corticosteroids affected this
manifestation in this patient is unclear. 
TNF-α mRNA was detectable in the lungs but not in
other tissues. This finding is in agreement with previous
observations that H5N1 viruses isolated from human dis-
ease hyperinduce production of cytokines, most promi-
nently TNF-α, in cultured human macrophages in vitro
(20,29). The simultaneous presence of viral mRNA and
cytokine mRNAin the same organ suggests a direct induc-
tion of cytokine in productively infected cells. In accor-
dance with this finding, we also found that the viral isolate
from this patient induced a high level of TNF-α production
from primary human macrophages, which is comparable to
the previously described strains (M. Peiris, unpub. data).
However, we could not rule out the possibility that the
superimposed fungal infection might have played a role in
the induction of TNF-α in this patient. The hemagglutinin
of the 1918 pandemic H1N1 influenza virus also appears
to hyperinduce production of cytokines and chemokines in
a mouse model of disease (30).
In conclusion, we have documented that H5N1 disease
in humans is one in which viral replication is restricted to
the respiratory and gastrointestinal tracts. The multiorgan
dysfunction observed in human H5N1 disease, despite the
apparent confinement of infection to the lungs, has
remained an enigma. The hypothesis that cytokine dysreg-
ulation may contribute to the pathogenesis of severe H5N1
disease (20) remains a possibility. An understanding of the
pathogenesis of human H5N1 disease is important in
preparing for a pandemic.
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